Preclinical

IntelGenx, ATAI partner on film-based psychedelics

03-Sep-2020 By Jenni Spinner

The companies will join forces to use IntelGenx’s polymeric film technologies for development of pharmaceutical-grade psychedelic drug treatments.

COVID-19 treatment study predicts adverse drug events

03-Sep-2020 By Jenni Spinner

Innovative research by Tabula Rasa Healthcare uses simulation technology to analyze potential adverse drug events of potential therapies for the virus.

COVID-19 report shares insights on potential therapies

01-Sep-2020 By Jenni Spinner

A new scientific report offers a comprehensive review of protein targets, associated COVID-19 drug candidates to date and other revealing information.

AstraZeneca, World Heart Federation partner on CV solutions

01-Sep-2020 By Jenni Spinner

The pharma firm and health association plan to collaborate in order to help drive global action toward prevention and control of cardiovascular disease.

NIAID awards $44m contract to advance COVID-19 drug

31-Aug-2020 By Jenni Spinner

The US institute has given a new contract to drug developer BioCryst to explore use of galidesivir in treatment of non-hospitalized COVID-19 patients.

Thermo Fisher expands cryo-EM access

31-Aug-2020 By Jenni Spinner

The company intends to enable pharma and biotech companies to have greater access to cryo-electronic microscopy for their research projects.

Front-line physicians offer COVID-19 insights

31-Aug-2020 By Jenni Spinner

A recent study from healthcare insights company Sermo shares information and perspectives that trial and pharma professionals could learn from.

Study looks at COVID-era mobile health applications

24-Aug-2020 By Jenni Spinner

Led by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemic’s effects.

Centogene database offers rare-disease insights

24-Aug-2020 By Jenni Spinner

The newly expanded CentoMD 5.8 mutation database includes clinical, epidemiologic and phenotypic data from more than 430,000 analyzed cases.

Duchenne foundation funds research leading to first-in-human clinical study

19-Aug-2020 By Jenni Spinner

The research taking place at Nationwide Children’s Hospital is seeking a treatment for a rare Duchenne muscular dystrophy mutation.

Cerba Research: collaboration boosts rare-disease discoveries

19-Aug-2020 By Jenni Spinner

A leader from the clinical laboratory and diagnostic solution provider discusses how its research is fueled by partnerships and patient-centricity.

Healx collaborates on Angelman syndrome therapies

19-Aug-2020 By Jenni Spinner

The AI-centric drug discovery technology firm is working with a foundation to discover potential treatments for the rare neurogenetic disorder.

Drug discovery platform aims to accelerate rare-disease therapies

19-Aug-2020 By Jenni Spinner

An online patient community specializing in rare diseases has launched Xperiome, a knowledge platform aimed at speeding development of treatments.

Notable, Washington University join on oncology study

19-Aug-2020 By Jenni Spinner

The precision study at the center of the partnership is geared toward identifying novel synergies across a broad variety of anticancer therapies.

Novateur study points toward potential COVID-19 treatment

17-Aug-2020 By Jenni Spinner

Researchers at Novateur Ventures have released a strategy that examines leukotrienes as the cause for hyperinflammatory response in severe cases.

Mission Bio raises $70m to help develop cancer therapies

17-Aug-2020 By Jenni Spinner

The company has landed $70m in Series C funding, with the purpose of accelerating development of cancer therapies with single-cell multiomics.

Trials can overcome COVID-created challenges: Medidata

10-Aug-2020 By Jenni Spinner

A leader from the clinical research solutions provider discusses the ways pandemic has shaken the trial industry, and how to tackle the obstacles.

Eversana partners on research data assessment

10-Aug-2020 By Jenni Spinner

The company is joining with ICER to help promote use of robust, repeatable indirect comparisons in health tech assessments.

PRA: get ready for the RACE Act

10-Aug-2020 By Jenni Spinner

Experts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.

Lab gears up to support COVID-19 trials

04-Aug-2020 By Jenni Spinner

Researchers at ACM Global Laboratories are focused on aiding clinical trials working on treatments for the deadly virus behind the current pandemic.

Research partnership delves into opioid alternatives

03-Aug-2020 By Jenni Spinner

Neurasic Therapeutics is borne from a collaborative effort intended to advance development of opioid-alternative pain relief.

Most recent FDA COVID-19 updates

30-Jul-2020 By Jenni Spinner

The US agency continues to put out informational resources, issue EUAs for tests and treatments, and monitor industry activity related to the virus.

Thermo Fischer Scientific backs 200+ COVID-19 projects globally

28-Jul-2020 By Jenni Spinner

The company is offering technology and support to projects around the world seeking to discover and produce vaccines and therapeutics.

Lonza: the right bio model can make a difference

27-Jul-2020 By Jenni Spinner

A leader from the health solutions and technology company explains how the proper biological models can enhance drug discovery and development.

InformedDNA: telemedicine connects genetic patients to clinical care

23-Jul-2020 By Jenni Spinner

A leader from the genetic services company discusses how use of telemedicine can help pull in patients and keep trials going.

Aigenpulse launches AI-based discovery platform

20-Jul-2020 By Jenni Spinner

The company is introducing technology using artificial intelligence and machine learning to accelerate drug discovery and development.

Aetion, Cegedim Health Data partner on European RWE effort

20-Jul-2020 By Jenni Spinner

The two firms will collaborate on an effort to integrate real-world data into clinical trial technology on a broad range of projects.

Health ‘ecosystem’ brings research, technology together

16-Jul-2020 By Jenni Spinner

An innovation-minded nonprofit organization aims to foster collaboration among scientists and tech minds, to fuel discovery and accelerate therapies.

Latest FDA advice and actions on COVID-19

15-Jul-2020 By Jenni Spinner

As the virus behind the pandemic continues to impact the globe, the federal agency continues to offer advice and take action in response to the virus.

Dewpoint and Merck in $305m deal for HIV ‘cure’

14-Jul-2020 By Ben Hargreaves

The two partners will use Dewpoint’s platform, focusing on biomolecular condensates, to treat the disease.

A-Alpha Bio lands Gates Foundation drug development grant

13-Jul-2020 By Jenni Spinner

The $800K grant will fund development of therapeutics for infectious diseases, including respiratory viruses like COVID-19, using machine learning.

Thermo Scientific workflow aims to accelerate drug development

29-Jun-2020 By Jenni Spinner

The iSPA Workflow, using single-particle analysis technology, is intended to help pharmaceutical bring drugs to market faster while conserving costs.

PRA brings Microsoft into COVID-19 monitoring tool

25-Jun-2020 By Jenni Spinner

The company has added the Microsoft Healthcare Bot service into its commercial Health Harmony COVID-19 Monitoring Program.

AI Vivo: dexamethasone shows promise as COVID-19 treatment

25-Jun-2020 By Jenni Spinner

The AI-focused pharma technology company reports researchers have determined the drug could save the lives of critically ill COVID-19 patents.

Parexel launches patient-centric research platform

22-Jun-2020 By Jenni Spinner

The company’s #KeepingPatientsFirst RWE platform uses Microsoft Azure cloud technology to help provide rapid access to critical COVID-19 data.

AI platform matches cancer patients to clinical trials, therapies

26-May-2020 By Jenni Spinner

The technology, developed by life-sciences software firm Deep Lens, integrates cancer genetic data into an advanced platform to connect patients with studies and treatments.

Immunai unveils map of human immune system

18-May-2020 By Jenni Spinner

A research team including MIT, Harvard and Stanford researchers has raised $20m in seed funding for their effort to map out immune cells with machine learning.

Research collaboration drives to accelerate COVID-19 solutions

04-May-2020 By Jenni Spinner

Led by Medable, the multi-company effort is geared toward ramping up development of treatments, diagnostics and other solutions for the pandemic-causing virus.

Almac Discovery collaborates with Merck on DUB targets

30-Apr-2020 By Jenni Spinner

The partnership will focus on generating novel small-molecule inhibitors against specific DUB targets for treatment of a range of diseases.

Novartis acquires digital therapeutics specialist Amblyotech

28-Apr-2020 By Jenni Spinner

The pharmaceutical firm has purchased the company, which specializes in advancing treatments and diagnostics for ocular disorders.

CAS open-access dataset to help COVID-19 research

28-Apr-2020 By Jenni Spinner

CAS, a division of the American Chemical Society, has released a dataset of chemical compounds with known or potential antiviral capabilities.

FDA update on COVID-19 actions and advisements

23-Apr-2020 By Jenni Spinner

Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.

Kore, Integron launch Critical Asset Management

21-Apr-2020 By Jenni Spinner

The managed services solution, intended for monitoring high-value items, enables pharmaceutical professionals to keep tables on critical items.

Vanda Pharmaceuticals partners with UIC on COVID-19 research

21-Apr-2020 By Jenni Spinner

The company and the University of Illinois at Chicago will work together to identify novel antivirals against COVID-19.

FDA updates and actions on COVID-19

01-Apr-2020 By Jenni Spinner

The federal agency has announced a slew of legislation, advisory statements and other items impacting the US in the face of the pandemic.

Gilead rescinds request for remdesivir orphan status

30-Mar-2020 By Jenni Spinner

The pharmaceutical company has withdrawn its orphan designation request for its antiviral for the treatment of COVID-19.

Gates Foundation enlists Novartis, GSK, others in COVID-19 fight

27-Mar-2020 By Jenni Spinner

The global collaboration brings together several pharmaceutical giants to accelerate the development and delivery of coronavirus tests and therapies.

MedPharm expands drug discovery lab facilities

26-Mar-2020 By Jenni Spinner

The newly expanded facility in Research Triangle park features a range of larger and added laboratory spaces, including a dedicated innovation lab.

zPredicta, LabCorp partner on 3D cell culture technology

26-Mar-2020 By Jenni Spinner

The collaboration supports the adoption of zPredicta’s 3D cell culture platform for preclinical testing and research studies.

PolarisQB, Fujitsu partner on drug discovery

24-Mar-2020 By Jenni Spinner

The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases.